30905309|t|Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model of Caenorhabditis elegans.
30905309|a|Objectives: Alzheimer's disease (AD) is a neurodegenerative disorder resulting from the accumulation of toxic beta-amyloid (Abeta) aggregates in the human brain. Epidemiological studies have shown that elevated cholesterol plasma levels are associated with the development of AD and we have previously shown that cholesterol restriction reduces the Abeta-induced paralysis in an Alzheimer model of the nematode Caenorhabditis elegans. In the present study we investigated the effects of the cholesterol homolog cholecalciferol, i.e. vitamin D, on Abeta-induced paralysis in C. elegans and its interference with the steroid-signaling pathway. Methods: Abeta-induced paralysis was assessed in the C. elegans strain CL2006, expressing human Abeta1-42 under control of a muscle-specific promoter. Knockdown of members of the steroid-signaling pathway was achieved by RNA interference (RNAi). Nuclear translocation of foxo transcription factor DAF-16 was visualized using the strain TJ356, carrying a daf-16::gfp transgene. Results: Cholecalciferol at a concentration of 1 microM reduced the Abeta-induced paralysis in CL2006 significantly, which was reverted by increasing the cholesterol concentration in the medium. Knockdown of nhr-8, daf-36, daf-9 or daf-12, all reduced Abeta-induced paralysis to the same extent as cholecalciferol with no additional or synergistic effects under co-application. Functional DAF-16 proved to be crucial for the effects of cholecalciferol and DAF-16 nuclear translocation was increased by cholecalciferol and also RNAi versus nhr-8, daf-36, daf-9 or daf-12 with no additive or synergistic effects. Conclusions: Our results suggest, that cholecalciferol inhibits Abeta-induced paralysis in C. elegans through inhibition of steroid-signaling and the concomitant nuclear translocation of DAF-16.
30905309	0	12	Amyloid-beta	Gene	351
30905309	21	30	paralysis	Disease	MESH:D010243
30905309	45	60	cholecalciferol	Chemical	MESH:D002762
30905309	87	94	steroid	Chemical	MESH:D013256
30905309	119	128	Alzheimer	Disease	MESH:D000544
30905309	138	160	Caenorhabditis elegans	Species	6239
30905309	174	193	Alzheimer's disease	Disease	MESH:D000544
30905309	195	197	AD	Disease	MESH:D000544
30905309	204	230	neurodegenerative disorder	Disease	MESH:D019636
30905309	286	291	Abeta	Gene	351
30905309	311	316	human	Species	9606
30905309	373	384	cholesterol	Chemical	MESH:D002784
30905309	438	440	AD	Disease	MESH:D000544
30905309	475	486	cholesterol	Chemical	MESH:D002784
30905309	511	516	Abeta	Gene	351
30905309	525	534	paralysis	Disease	MESH:D010243
30905309	541	550	Alzheimer	Disease	MESH:D000544
30905309	573	595	Caenorhabditis elegans	Species	6239
30905309	653	664	cholesterol	Chemical	MESH:D002784
30905309	673	688	cholecalciferol	Chemical	MESH:D002762
30905309	695	704	vitamin D	Chemical	MESH:D014807
30905309	709	714	Abeta	Gene	351
30905309	723	732	paralysis	Disease	MESH:D010243
30905309	736	746	C. elegans	Species	328850
30905309	777	784	steroid	Chemical	MESH:D013256
30905309	813	818	Abeta	Gene	351
30905309	827	836	paralysis	Disease	MESH:D010243
30905309	857	867	C. elegans	Species	328850
30905309	875	881	CL2006	Chemical	-
30905309	894	899	human	Species	9606
30905309	983	990	steroid	Chemical	MESH:D013256
30905309	1101	1107	DAF-16	Gene	172981
30905309	1158	1169	daf-16::gfp	Gene	172981
30905309	1190	1205	Cholecalciferol	Chemical	MESH:D002762
30905309	1249	1254	Abeta	Gene	351
30905309	1263	1272	paralysis	Disease	MESH:D010243
30905309	1276	1282	CL2006	Chemical	-
30905309	1335	1346	cholesterol	Chemical	MESH:D002784
30905309	1389	1394	nhr-8	Gene	177551
30905309	1396	1402	daf-36	Gene	179422
30905309	1404	1409	daf-9	Gene	180889
30905309	1413	1419	daf-12	Gene	181263
30905309	1433	1438	Abeta	Gene	351
30905309	1447	1456	paralysis	Disease	MESH:D010243
30905309	1479	1494	cholecalciferol	Chemical	MESH:D002762
30905309	1570	1576	DAF-16	Gene	172981
30905309	1617	1632	cholecalciferol	Chemical	MESH:D002762
30905309	1637	1643	DAF-16	Gene	172981
30905309	1683	1698	cholecalciferol	Chemical	MESH:D002762
30905309	1720	1725	nhr-8	Gene	177551
30905309	1727	1733	daf-36	Gene	179422
30905309	1735	1740	daf-9	Gene	180889
30905309	1744	1750	daf-12	Gene	181263
30905309	1831	1846	cholecalciferol	Chemical	MESH:D002762
30905309	1856	1861	Abeta	Gene	351
30905309	1870	1879	paralysis	Disease	MESH:D010243
30905309	1883	1893	C. elegans	Species	328850
30905309	1916	1923	steroid	Chemical	MESH:D013256
30905309	1979	1985	DAF-16	Gene	172981
30905309	Negative_Correlation	MESH:D002762	MESH:D010243
30905309	Negative_Correlation	MESH:D002762	MESH:D000544
30905309	Association	MESH:D002784	MESH:D010243
30905309	Association	180889	351
30905309	Association	MESH:D010243	179422
30905309	Negative_Correlation	MESH:D002762	MESH:D013256
30905309	Positive_Correlation	MESH:D002762	172981
30905309	Association	MESH:D010243	181263
30905309	Association	179422	351
30905309	Association	MESH:D002762	MESH:D002784
30905309	Negative_Correlation	MESH:D002762	351
30905309	Association	172981	177551
30905309	Negative_Correlation	MESH:D002784	351
30905309	Association	181263	351
30905309	Association	177551	351
30905309	Association	MESH:D000544	351
30905309	Positive_Correlation	MESH:D010243	351
30905309	Association	MESH:D010243	180889
30905309	Association	MESH:D010243	177551
30905309	Positive_Correlation	MESH:D002784	MESH:D000544

